scholarly article | Q13442814 |
P356 | DOI | 10.1089/ARS.2009.2459 |
P8608 | Fatcat ID | release_kjxwkh2yivfzlhcifrklkybpvy |
P932 | PMC publication ID | 2935343 |
P698 | PubMed publication ID | 19450058 |
P50 | author | M. Flint Beal | Q67409129 |
P2093 | author name string | Yoon-Seong Kim | |
Dong-Hee Choi | |||
Ana Clara Cristóvão | |||
Graça Baltazar | |||
P2860 | cites work | Cell transformation by the superoxide-generating oxidase Mox1 | Q22010372 |
Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family | Q22254073 | ||
SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model | Q24307703 | ||
Nox1-dependent reactive oxygen generation is regulated by Rac1 | Q24320021 | ||
Involvement of Rac1 in activation of multicomponent Nox1- and Nox3-based NADPH oxidases | Q24548021 | ||
Paraquat: model for oxidant-initiated toxicity | Q24669894 | ||
Pesticides and Parkinson's disease--is there a link? | Q25257240 | ||
Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5 | Q28190953 | ||
Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat | Q28215248 | ||
The role of microglia in paraquat-induced dopaminergic neurotoxicity | Q46487161 | ||
Inhibition of thrombin-induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo | Q46747415 | ||
NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke | Q46966136 | ||
Biochemical aspects of phagocytosis in polymorphonuclear leucocytes. NADH and NADPH oxidation by the granules of resting and phagocytizing cells | Q46990426 | ||
NOX1/NADPH oxidase negatively regulates nerve growth factor-induced neurite outgrowth. | Q54603335 | ||
Lifestyle-related risk factors for Parkinson's disease: a population-based study | Q57273921 | ||
Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. | Q67403760 | ||
Mitochondrial complex I deficiency in Parkinson's disease | Q69370277 | ||
Link between mitochondria and NADPH oxidase 1 isozyme for the sustained production of reactive oxygen species and cell death | Q79173774 | ||
A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation | Q79372306 | ||
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease | Q28317593 | ||
Immunohistochemical study of p47Phox and gp91Phox distributions in rat brain | Q28564761 | ||
Oxidative stress in Parkinson's disease | Q29618017 | ||
NADPH oxidases of the brain: distribution, regulation, and function | Q31061677 | ||
Mitochondria, oxidative damage, and inflammation in Parkinson's disease | Q34212155 | ||
Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons. | Q34214876 | ||
Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone | Q34378188 | ||
Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase | Q34722527 | ||
Current molecular models for NADPH oxidase regulation by Rac GTPase | Q34915029 | ||
Mitochondria are a major source of paraquat-induced reactive oxygen species production in the brain | Q34936383 | ||
Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons | Q35786982 | ||
Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration | Q36026636 | ||
Synaptic localization of a functional NADPH oxidase in the mouse hippocampus | Q36051340 | ||
Cytotoxicity of paraquat in microglial cells: Involvement of PKCdelta- and ERK1/2-dependent NADPH oxidase | Q36156588 | ||
Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells | Q36275187 | ||
A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. | Q36880536 | ||
Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease | Q37110410 | ||
Classical inhibitors of NOX NAD(P)H oxidases are not specific. | Q37294085 | ||
Parkinson's disease: a case-control study of occupational and environmental risk factors. | Q39102287 | ||
Free radical mediated cell toxicity by redox cycling chemicals | Q39137970 | ||
Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones | Q39615110 | ||
The AP-1 site is essential for the promoter activity of NOX1/NADPH oxidase, a vascular superoxide-producing enzyme: Possible involvement of the ERK1/2-JunB pathway | Q39959652 | ||
Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. | Q40034272 | ||
Rac1-NADPH oxidase-regulated generation of reactive oxygen species mediates glutamate-induced apoptosis in SH-SY5Y human neuroblastoma cells | Q40349340 | ||
Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors | Q40350108 | ||
Paraquat neurotoxicity is distinct from that of MPTP and rotenone. | Q40377576 | ||
Superoxide dismutase/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra: implications for Parkinson disease | Q40411589 | ||
PKCdelta mediates up-regulation of NOX1, a catalytic subunit of NADPH oxidase, via transactivation of the EGF receptor: possible involvement of PKCdelta in vascular hypertrophy | Q40418087 | ||
Parkinson's disease: a disorder due to nigral glutathione deficiency? | Q41628096 | ||
Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy | Q41632791 | ||
Apocynin improves outcome in experimental stroke with a narrow dose range | Q42403010 | ||
Expression and modulation of an NADPH oxidase in mammalian astrocytes. | Q42484955 | ||
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease | Q43624453 | ||
Environmental risk factors and Parkinson's disease: a case-control study in Taiwan | Q43699090 | ||
The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein | Q43798526 | ||
Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. | Q44264439 | ||
NADPH oxidase immunoreactivity in the mouse brain | Q44602831 | ||
Neurodegenerative diseases and oxidative stress | Q44805871 | ||
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease | Q44808814 | ||
Reactive oxygen species derived from NOX1/NADPH oxidase enhance inflammatory pain. | Q46361361 | ||
Role of oxidative stress in paraquat-induced dopaminergic cell degeneration. | Q46460372 | ||
P433 | issue | 9 | |
P921 | main subject | dopamine | Q170304 |
reactive oxygen species | Q424361 | ||
cell death | Q2383867 | ||
P304 | page(s) | 2105-2118 | |
P577 | publication date | 2009-09-01 | |
P1433 | published in | Antioxidants & Redox Signaling | Q4775078 |
P1476 | title | The role of NADPH oxidase 1-derived reactive oxygen species in paraquat-mediated dopaminergic cell death | |
P478 | volume | 11 |
Q35102608 | AMP-activated protein kinase deficiency rescues paraquat-induced cardiac contractile dysfunction through an autophagy-dependent mechanism |
Q34211654 | Alterations in energy/redox metabolism induced by mitochondrial and environmental toxins: a specific role for glucose-6-phosphate-dehydrogenase and the pentose phosphate pathway in paraquat toxicity |
Q37647941 | Antioxidant gene therapy against neuronal cell death |
Q41658073 | Cardiac-Specific Knockout of ETA Receptor Mitigates Paraquat-Induced Cardiac Contractile Dysfunction |
Q41297634 | Cardiac-specific overexpression of catalase attenuates paraquat-induced myocardial geometric and contractile alteration: role of ER stress |
Q92156064 | Carnosol Improved Lifespan and Healthspan by Promoting Antioxidant Capacity in Caenorhabditis elegans |
Q37445587 | Compartmentalized oxidative stress in dopaminergic cell death induced by pesticides and complex I inhibitors: distinct roles of superoxide anion and superoxide dismutases |
Q33628892 | Correlation between anthropometric measurement, lipid profile, dietary vitamins, serum antioxidants, lipoprotein (a) and lipid peroxides in known cases of 345 elderly hypertensive South Asian aged 56-64 y-A hospital based study |
Q35591362 | Deficiency of multidrug and toxin extrusion 1 enhances renal accumulation of paraquat and deteriorates kidney injury in mice |
Q30541996 | Diapocynin prevents early Parkinson's disease symptoms in the leucine-rich repeat kinase 2 (LRRK2R¹⁴⁴¹G) transgenic mouse |
Q52787645 | Effect of low doses of herbicide paraquat on antioxidant defense in Drosophila. |
Q61809069 | Elucidating Conserved Transcriptional Networks Underlying Pesticide Exposure and Parkinson's Disease: A Focus on Chemicals of Epidemiological Relevance |
Q39184327 | Entamoeba histolytica induces cell death of HT29 colonic epithelial cells via NOX1-derived ROS. |
Q35062927 | Exposure to anesthetic gases and Parkinson's disease: a case report |
Q40745212 | Fluorescence labeling of carbonylated lipids and proteins in cells using coumarin-hydrazide |
Q51033505 | Free radicals impair the anti-oxidative stress activity of DJ-1 through the formation of SDS-resistant dimer. |
Q35416073 | Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade. |
Q30276672 | Histamine induces microglia activation and dopaminergic neuronal toxicity via H1 receptor activation |
Q34082536 | Histidine affinity chromatography-based methodology for the simultaneous isolation of Escherichia coli small and ribosomal RNA. |
Q36188186 | Integrating cytosolic phospholipase A₂ with oxidative/nitrosative signaling pathways in neurons: a novel therapeutic strategy for AD. |
Q64237303 | Ligustrazin increases lung cell autophagy and ameliorates paraquat-induced pulmonary fibrosis by inhibiting PI3K/Akt/mTOR and hedgehog signalling via increasing miR-193a expression |
Q35657214 | Lithium protects against paraquat neurotoxicity by NRF2 activation and miR-34a inhibition in SH-SY5Y cells |
Q34764783 | Matrix metalloproteinase-3 causes dopaminergic neuronal death through Nox1-regenerated oxidative stress |
Q48283898 | Minocycline Rescues from Zinc-Induced Nigrostriatal Dopaminergic Neurodegeneration: Biochemical and Molecular Interventions |
Q38855994 | Mito-Apocynin Prevents Mitochondrial Dysfunction, Microglial Activation, Oxidative Damage, and Progressive Neurodegeneration in MitoPark Transgenic Mice |
Q41349377 | Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson's Disease. |
Q35240549 | Mitochondrial aconitase knockdown attenuates paraquat-induced dopaminergic cell death via decreased cellular metabolism and release of iron and H₂O₂. |
Q34142918 | Molecular mechanisms of pesticide-induced neurotoxicity: Relevance to Parkinson's disease |
Q38717576 | Multifactorial theory applied to the neurotoxicity of paraquat and paraquat-induced mechanisms of developing Parkinson's disease |
Q64778733 | NADPH Oxidase Mediates Membrane Androgen Receptor-Induced Neurodegeneration. |
Q36408665 | NADPH oxidase 1 mediates α-synucleinopathy in Parkinson's disease |
Q33860500 | NADPH oxidase 1, a novel molecular source of ROS in hippocampal neuronal death in vascular dementia |
Q30512262 | NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease |
Q37589114 | NADPH oxidase in brain injury and neurodegenerative disorders |
Q46262582 | NADPH oxidases in Parkinson's disease: a systematic review |
Q36336772 | NADPH oxidases: novel therapeutic targets for neurodegenerative diseases |
Q38738244 | Neuronal protection against oxidative insult by polyanhydride nanoparticle-based mitochondria-targeted antioxidant therapy. |
Q90694792 | Neuropathological Mechanisms Associated with Pesticides in Alzheimer's Disease |
Q38193220 | New insights into antioxidant strategies against paraquat toxicity |
Q33632673 | New insights on NOX enzymes in the central nervous system |
Q34110134 | Nox-4-dependent nuclear H2O2 drives DNA oxidation resulting in 8-OHdG as urinary biomarker and hemangioendothelioma formation |
Q54977318 | Organophosphate pesticide chlorpyrifos impairs STAT1 signaling to induce dopaminergic neurotoxicity: Implications for mitochondria mediated oxidative stress signaling events. |
Q34203215 | Oxidative toxicity in neurodegenerative diseases: role of mitochondrial dysfunction and therapeutic strategies |
Q37138890 | PKCδ mediates paraquat-induced Nox1 expression in dopaminergic neurons |
Q46732854 | Paraquat Induces Cell Death Through Impairing Mitochondrial Membrane Permeability. |
Q64980378 | Paraquat disrupts the anti-inflammatory action of cortisol in human macrophages in vitro: therapeutic implications for paraquat intoxications. |
Q35651220 | Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3. |
Q61875301 | Paraquat: Molecular Mechanisms of Neurotoxicity and its Relation with Autophagy |
Q33644302 | Parkinson's disease: from molecular pathways in disease to therapeutic approaches |
Q41507019 | Parkinsonian toxin-induced oxidative stress inhibits basal autophagy in astrocytes via NQO2/quinone oxidoreductase 2: Implications for neuroprotection. |
Q39161246 | Pikuni-Blackfeet traditional medicine: Neuroprotective activities of medicinal plants used to treat Parkinson's disease-related symptoms |
Q86622962 | Protective Effects of Arachidonic Acid Against Paraquat-Induced Pulmonary Injury |
Q35892077 | Radix puerariae extracts ameliorate paraquat-induced pulmonary fibrosis by attenuating follistatin-like 1 and nuclear factor erythroid 2p45-related factor-2 signalling pathways through downregulation of miRNA-21 expression |
Q88968501 | Revisiting the Paraquat-Induced Sporadic Parkinson's Disease-Like Model |
Q37343565 | Rodent models of Parkinson's disease: beyond the motor symptomatology |
Q35009071 | Role of neuronal NADPH oxidase 1 in the peri-infarct regions after stroke |
Q37234036 | Specific carotenoid pigments in the diet and a bit of oxidative stress in the recipe for producing red carotenoid-based signals |
Q93269919 | Targeted delivery of nanomaterials with chemical cargoes in plants enabled by a biorecognition motif |
Q34285497 | Targeting NOX enzymes in the central nervous system: therapeutic opportunities. |
Q45986289 | The Mitochondrial Lon Protease Is Required for Age-Specific and Sex-Specific Adaptation to Oxidative Stress. |
Q59326775 | The Plasma Membrane: A Platform for Intra- and Intercellular Redox Signaling |
Q64273363 | The Role of NOX4 in Parkinson's Disease with Dementia |
Q42253314 | The antidote effect of quinone oxidoreductase 2 inhibitor against paraquat-induced toxicity in vitro and in vivo. |
Q38086654 | The beneficial role of thiamine in Parkinson disease. |
Q35469632 | The endoplasmic reticulum-associated degradation is necessary for plant salt tolerance |
Q37971725 | The neuroprotective effects of apocynin |
Q38108496 | The role of β-adrenergic blockers in Parkinson's disease: possible genetic and cell-signaling mechanisms |
Q46814011 | Therapeutic effects of fucoidan in 6-hydroxydopamine-lesioned rat model of Parkinson's disease: Role of NADPH oxidase-1. |
Q38858553 | Therapeutic potential of NADPH oxidase 1/4 inhibitors |
Q36326535 | Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease |
Q38038831 | Vitamin D and Parkinson's disease |
Q28488163 | Vitamin E ameliorates the decremental effect of paraquat on cardiomyocyte contractility in rats |
Q30355898 | siRNA-mediated knock-down of NOX3: therapy for hearing loss? |
Search more.